Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

PREcision MEDicin vid Achalasia (PREMEDIA) (PREMEDIA)

10 november 2026 uppdaterad av: John Pandolfino, Northwestern University

PRECision MEDicin vid Achalasia - En multicenter randomiserad icke-underlägsenhetsstudie av kort skräddarsydd POEM jämfört med standard POEM för icke-spastisk achalasia och en multicenter prospektiv kohortstudie av lång skräddarsydd POEM för spastiska esofageala motoriska störningar

The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:

  • Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
  • Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.

Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.

Studieöversikt

Detaljerad beskrivning

The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.

Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.

Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.

Studietyp

Interventionell

Inskrivning (Beräknad)

372

Fas

  • Fas 3

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

    • Arizona
      • Scottsdale, Arizona, Förenta staterna, 85259
        • Har inte rekryterat ännu
        • Mayo Clinic Arizona
    • California
      • La Jolla, California, Förenta staterna, 92037
        • Rekrytering
        • University of California San Diego
        • Huvudutredare:
          • Rena Yadlapati, MD
        • Kontakt:
    • Colorado
      • Denver, Colorado, Förenta staterna, 80217
        • Har inte rekryterat ännu
        • University of Colorado Denver
    • Florida
      • Gainesville, Florida, Förenta staterna, 32611
        • Rekrytering
        • University of Florida
        • Huvudutredare:
          • Peter Draganov, MD
        • Kontakt:
      • Orlando, Florida, Förenta staterna, 32803
        • Har inte rekryterat ännu
        • Adventist Health System/Sunbelt, Inc
    • Georgia
      • Atlanta, Georgia, Förenta staterna, 30322
        • Rekrytering
        • Emory University
        • Huvudutredare:
          • Anand Jain, MD
        • Kontakt:
    • Illinois
      • Chicago, Illinois, Förenta staterna, 60611
        • Rekrytering
        • Northwestern University
        • Huvudutredare:
          • John Pandolfino, MD
        • Kontakt:
    • Maryland
      • Baltimore, Maryland, Förenta staterna, 21218
        • Har inte rekryterat ännu
        • Johns Hopkins University
    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02114
        • Rekrytering
        • Massachusetts General Hospital
        • Kontakt:
          • Madison Paylor, Lead Study Coordinator
          • Telefonnummer: 617-726-0196
          • E-post: premedia@mgb.org
        • Huvudutredare:
          • Kyle Staller, MD
    • Missouri
      • St Louis, Missouri, Förenta staterna, 63110
        • Rekrytering
        • Washington University
        • Kontakt:
        • Huvudutredare:
          • Chandra Gyawali, MD
    • New York
      • New York, New York, Förenta staterna, 10065
        • Har inte rekryterat ännu
        • Weill Cornell Medical College
    • North Carolina
      • Charlotte, North Carolina, Förenta staterna, 28204
        • Rekrytering
        • Atrium Health/Wake Forest
        • Huvudutredare:
          • Badih Elmunzer, MD
        • Kontakt:
    • Ohio
      • Cleveland, Ohio, Förenta staterna, 44109
        • Rekrytering
        • MetroHealth Medical Center
        • Huvudutredare:
          • Ronnie Fass, MD
        • Kontakt:
      • Cleveland, Ohio, Förenta staterna, 44106
        • Har inte rekryterat ännu
        • Case Western Reserve University
    • Tennessee
      • Nashville, Tennessee, Förenta staterna, 37232
        • Rekrytering
        • Vanderbilt University Medical Center
        • Huvudutredare:
          • Dhyanesh Patel, MD
        • Kontakt:
    • Texas
      • Dallas, Texas, Förenta staterna, 75246
        • Rekrytering
        • Baylor Scott & White Health
        • Kontakt:
        • Huvudutredare:
          • Vani Albertson Konda, MD

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria

  1. Age ≥ 18
  2. Type I achalasia or type II achalasia or cEGJOO
  3. Eckardt score > 3

Exclusion Criteria

The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:

  1. Prior POEM
  2. Prior surgical treatment for achalasia
  3. Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
  4. Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
  5. Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
  6. Known secondary achalasia related to malignancy (pseudoachalasia)
  7. Known eosinophilic esophagitis
  8. Diverticulum (> 2 cm) in distal esophagus
  9. Megaesophagus
  10. Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
  11. Pregnancy
  12. Standard contraindications to general anesthesia
  13. Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
  14. Unwillingness or inability to consent for the study
  15. Anticipated inability to follow protocol
  16. Weekly (or more frequent) opioid medication use in the last 2 years

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Fyrdubbla

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Standard Myotomi

Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy.

Experimentell: Skräddarsydd kort myotomi

Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Clinical Response-Overall
Tidsram: From enrollment to Year 2

Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

From enrollment to Year 2
Clinical Response-by Sex
Tidsram: From enrollment to Year 2

Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

From enrollment to Year 2
Clinical Response-by Race
Tidsram: From Enrollment to Year 2

Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

From Enrollment to Year 2
Clinical Response-by Ethnicity
Tidsram: From Enrollment to Year 2

Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

From Enrollment to Year 2

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

29 april 2026

Primärt slutförande (Beräknad)

1 augusti 2031

Avslutad studie (Beräknad)

1 augusti 2032

Studieregistreringsdatum

Först inskickad

17 december 2025

Först inskickad som uppfyllde QC-kriterierna

17 december 2025

Första postat (Faktisk)

19 december 2025

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

12 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 november 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV
  • CSR

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera